Not all patent licensing businesses are alike. “NPE 2016: The Business of Responsible Licensing,” scheduled for March 22 at the Convene conference in New York,

Not all patent licensing businesses are alike. “NPE 2016: The Business of Responsible Licensing,” scheduled for March 22 at the Convene conference in New York,
A new weekly is the first to feature in-depth coverage of public intellectual property monetization companies (PIPCOs). I’ve been following The Patent Investor for a
More and better patents have greater meaning for licensors now that a petitioner can seek an internal review (IPR) canceling a patent because of a
Finjan, Inventergy, Network-1, Straight Talk and Universal Display have been added to the IP licensing company (PIPCO) stock index, IP Close Up 30. To remain
Despite their increased size and capital most small public companies that rely significantly on patent licensing have yet to prove they can compete with other
IP CloseUp’s most active day increased more than ten-fold. IP CloseUp was viewed about 16,000 times last year. If it were a concert at Carnegie
Bad actors no more define all NPEs than they do all high-tech companies, even though many use inventions without paying. A nasty dispute involving an
“When Patents Attack… Part II!” revisits old ground about bad IP actors by relying on half-truths and high drama. “This American Life,” an entertaining weekly
No company has more Active U.S. patents than Samsung or files more applications. In fact, outside of IBM, Samsung leads all filers in U.S. patent
Report says that funding will hinge on a $500 million deal. A story from Reuters that appears today in The NY Times online and was
Flawed IP Report Attempts to Legitimize Assertion Label If the Congressional Research Service’s distorted findings on the impact of patent holders are not bad enough,
There is a Tendency to View Patent Prowess as a Function of Reputation and Perceived Innovation Much of billion dollar verdict in Apple v. Samsung